Abbott Laboratories
$93.07
▲
0.41%
2026-04-22 10:12:13
www.abbott.com
NYQ: ABT
Explore Abbott Laboratories stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$162.16 B
Current Price
$93.07
52W High / Low
$139.06 / $93.92
Stock P/E
25.91
Book Value
$30.02
Dividend Yield
2.6%
ROCE
11.47%
ROE
12.96%
Face Value
—
EPS
$3.59
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
115,000
Beta
0.78
Debt / Equity
26.79
Current Ratio
1.58
Quick Ratio
1.18
Forward P/E
16.42
Price / Sales
3.93
Enterprise Value
$180.13 B
EV / EBITDA
14.97
EV / Revenue
4.06
Rating
Buy
Target Price
$131.44
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 2. | Elutia Inc. | $1.12 | 0.92 | $49.2 M | — | -49.48% | -574.35% | $2.64 / $0.5 | $0.65 |
| 3. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 4. | Masimo Corporation | $178.4 | 46.03 | $9.34 B | — | 23.57% | 23.43% | $179 / $125.94 | $13.84 |
| 5. | Modular Medical, Inc. | $5.41 | — | $27.31 M | — | -109.03% | -3.32% | $34.5 / $3.55 | $2.27 |
| 6. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
| 7. | Hyperfine, Inc. | $1.29 | — | $128.32 M | — | -85.19% | -79.01% | $2.22 / $0.53 | $0.42 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 11.46 B | 11.37 B | 11.14 B | 10.36 B | 10.97 B |
| Operating Profit | 2.25 B | 2.06 B | 2.05 B | 1.69 B | 1.91 B |
| Net Profit | 1.78 B | 1.64 B | 1.78 B | 1.32 B | 9.23 B |
| EPS in Rs | 1.02 | 0.95 | 1.02 | 0.76 | 5.31 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 44.33 B | 41.95 B | 40.11 B | 43.65 B |
| Operating Profit | 8.05 B | 6.83 B | 6.48 B | 8.36 B |
| Net Profit | 6.52 B | 13.4 B | 5.72 B | 6.93 B |
| EPS in Rs | 3.75 | 7.71 | 3.29 | 3.99 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 86.71 B | 81.41 B | 73.21 B | 74.44 B |
| Total Liabilities | 33.94 B | 33.51 B | 34.39 B | 37.53 B |
| Equity | 52.13 B | 47.66 B | 38.6 B | 36.69 B |
| Current Assets | 26 B | 23.66 B | 22.67 B | 25.22 B |
| Current Liabilities | 16.5 B | 14.16 B | 13.84 B | 15.49 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 9.57 B | 8.56 B | 7.26 B | 9.58 B |
| Investing CF | -2.42 B | -2.34 B | -3.13 B | -1.74 B |
| Financing CF | -6.31 B | -5.4 B | -7.09 B | -7.64 B |
| Free CF | 7.39 B | 6.35 B | 5.06 B | 7.8 B |
| Capex | -2.17 B | -2.21 B | -2.2 B | -1.78 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.59% | -8.12% | — | — |
| Earnings Growth % | 134.18% | -17.45% | — | — |
| Profit Margin % | 31.95% | 14.27% | 15.88% | — |
| Operating Margin % | 16.27% | 16.15% | 19.16% | — |
| Gross Margin % | 55.41% | 55.18% | 56.15% | — |
| EBITDA Margin % | 25.72% | 26.29% | 27.79% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-01-15 | $0.63 |
| 2025-10-15 | $0.59 |
| 2025-07-15 | $0.59 |
| 2025-04-15 | $0.59 |
| 2025-01-15 | $0.59 |
Stock Splits
No stock split history available.